吉林长龙药业认购5000万元工商银行理财产品

Core Viewpoint - Jilin Changlong Pharmaceutical (08049) announced the subscription of a financial product from Industrial and Commercial Bank of China for an amount of RMB 50 million, scheduled for August 21, 2025 [1] Company Summary - The company is engaging in a financial investment by subscribing to a financial product, indicating a strategic move to manage its liquidity or invest surplus cash [1]